Stocks and InvestingStocks and Investing
Thu, July 6, 2023
Wed, July 5, 2023
Mon, July 3, 2023
Fri, June 30, 2023

Francois Brisebois Maintained (AVDL) at Buy with Increased Target to $25 on, Jun 30th, 2023


Published on 2024-10-28 04:36:20 - WOPRAI, Francois Brisebois
  Print publication without navigation


Francois Brisebois of Oppenheimer, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $22 to $25 on, Jun 30th, 2023.

Francois has made no other calls on AVDL in the last 4 months.



There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with Francois's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Francois


  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $16 on, Tuesday, May 2nd, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 2nd, 2023
  • Patrick Dolezal of "LifeSci Capital" Maintained at Buy with Increased Target to $26 on, Tuesday, May 2nd, 2023